This phase 1/2 single-arm trial examined toxic effects, local control, and overall survival rates after chemoradiotherapy with a simultaneous integrated boost of radiotherapy dose to the gross tumor and nodal disease for patients with unresectable locally advanced esophageal cancer.
Explore special articles published online first to coincide with presentations at the European Society for Medical Oncology ESMO Congress 2019.
Explore special articles published online first to coincide with presentations at the European Society for Medical Oncology ESMO Congress 2019.
This cross-sectional study describes national and regional Medicare spending and out-of-pocket costs for tafamidis from its approval in 2019 to 2021.
The US government has reached an agreement with drug companies to lower the price of 10 common prescription medications for people who are covered by…
This consensus study presents recommendations from a 51-member working group regarding kidney follow-up care for infants discharged from the neonatal intensive care unit.
This Medical News article discusses research that found Black individuals and women are less likely to survive after receiving cardiopulmonary resuscitation for out-of-hospital cardiac arrest…
This national cohort survey of older adults assesses which health-related concerns they consider to be most salient in the 2024 election.
This cohort study examines weight outcomes at 1 year in patients with obesity who received injectable forms of liraglutide or semaglutide compared by agent, indication,…
This randomized, multisite, comparative effectiveness trial investigates whether early palliative care delivered via video or in-person visits demonstrated equivalent effects on quality of life for…
This cross-sectional study examines whether synthetic nicotine e-cigarette brands implemented Food and Drug Administration health warning requirements and evaluates the association between health warnings and…
